Menu
- Office Hour : 08:00am - 6:00pm
At Cohance Lifesciences, we bring scientific rigor and operational agility to the development of small molecule APIs, advanced intermediates and starting materials. Our end-to-end capabilities span route scouting, process optimization, analytical development, and regulatory documentation—empowering innovators to move confidently from concept to clinic.
With deep expertise across hazardous, moisture-sensitive, and stereoselective chemistries, our dedicated process R&D teams engineer robust, scalable, and cost-effective synthesis pathways. Every step is underpinned by integrated process safety, data integrity, and global compliance, ensuring a smooth transition to GMP manufacturing and regulatory submissions.
Efficient identification of optimal synthetic routes using DoE and feasibility studies.
Risk-informed development, impurity profiling, and scalable optimization for cost and purity.
Custom methods, impurity markers, validation, and stability-indicating assays.
State-of-the-art safety studies (RC1, DSC, ARC) to ensure secure scale-up.
Comprehensive support for IND, IMPD, and DMF submissions across global markets.
Efficient identification of optimal synthetic routes using DoE and feasibility studies.
Risk-informed development, impurity profiling, and scalable optimization for cost and purity.
Custom methods, impurity markers, validation, and stability-indicating assays.
State-of-the-art safety studies (RC1, DSC, ARC) to ensure secure scale-up.
Comprehensive support for IND, IMPD, and DMF submissions across global markets.